Avai Bio (AVAI) Market Capitalization (2020 - 2026)

Avai Bio has disclosed Market Capitalization across 7 years of filings, most recently posting $20.0 million for Q2 2026.

• In Q2 2026, Market Capitalization fell 75.34% year-over-year to $20.0 million; the TTM figure through Jun 2026 stood at $20.0 million (down 75.34% YoY), while the FY2026 annual figure was $49.0 million, down 25.64% from the prior year.
• Market Capitalization came in at $20.0 million for Q2 2026 at Avai Bio, down from $49.0 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $100.6 million in Q2 2024 to a low of $20.0 million in Q2 2026.
• Average Market Capitalization over 5 years is $57.8 million, with a median of $56.8 million recorded in 2023.
• Year-over-year, Market Capitalization surged 205.31% in 2023 and tumbled 75.34% in 2026.
• Over 5 years, Market Capitalization stood at $40.8 million in 2022, then surged by 39.28% to $56.8 million in 2023, then grew by 25.52% to $71.3 million in 2024, then dropped by 26.44% to $52.5 million in 2025, then slumped by 61.85% to $20.0 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $20.0 million in Q2 2026, $49.0 million in Q1 2026, and $52.5 million in Q4 2025.